Plain-English translation of NCT07018661 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new type of scan called FAPI-PET/CT to help doctors find out whether stomach cancer has spread to other parts of your body. The scan uses a small amount of radioactive tracer ([18F]F-FAPI-74) that is injected into your bloodstream, and it may be better at finding cancer spread than the scans doctors currently use. The researchers want to see whether this new scan can help avoid unnecessary surgeries and guide treatment decisions more accurately.
Doctors currently use standard CT scans and other tests to check if stomach cancer has spread, but these tests sometimes miss cancer that has spread to distant sites. A better scanning method could help avoid operations that won't help patients and guide doctors toward the most appropriate treatment for each person.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive one additional scan beyond your regular care. First, a small amount of radioactive tracer will be injected into your arm, and after about an hour, you will lie still in the scanner for approximately 20 minutes while it takes pictures. The entire visit will take about 2 hours. You will also be asked to complete some questionnaires about your quality of life and medical costs, which will take about 4 hours total. All of this happens in addition to your standard cancer care and planned surgery.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Netherlands